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Abstract: Several recent studies have revealed previously unknown complexity of the amphibian
interferon (IFN) system. Being unique in vertebrate animals, amphibians not only conserve and
multiply the fish-like intron-containing IFN genes, but also rapidly evolve amniote-like intronless IFN
genes in each tested species. We postulate that the amphibian IFN system confers an essential model to
study vertebrate immune evolution in molecular and functional diversity to cope with unprecedented
pathophysiological requirement during terrestrial adaption. Studies so far have ascribed a potential
role of these IFNs in immune regulation against intracellular pathogens, particularly viruses; however,
many knowledge gaps remain elusive. Based on recent reports about IFN’s multifunctional properties
in regulation of animal physiological and defense responses, we interpret that amphibian IFNs may
evolve novel function pertinent to their superior molecular diversity. Such new function revealed by
the emerging studies about antifungal and developmental regulation of amphibian IFNs will certainly
promote our understanding of immune evolution in vertebrates to address current pathogenic threats
causing amphibian decline.
Keywords: amphibian; Xenopus; interferons; antiviral; immune evolution
1. The Unique Complexity and Role of Amphibian Interferons (IFNs) in Immune Evolution
The animal immune system relies on a series of specified immune molecules, collectively known
as immunome, to detect and repel pathogenic invaders at the molecular, cellular, and organismal levels.
Species-specific or cross-species characterization of the immunome lays a cornerstone in studying
animal health and immune evolution [1–3]. Interferon (IFN)-mediated immune response involves IFNs
and several hundreds of IFN-stimulated genes (ISGs) that play a pivotal role in antiviral defense [4–7].
Coincided with the evolution of adaptive immunity, IFN genes also originate in jawed fish from a few
multi-exon progenitors [8]. Primitive IFN-like molecules have been previously determined in bony fish,
with discernible IFN-γ- and IFN-φ-like genes, which are presumed to be progenitors of type II (IFN-II,
IFN-γ) and type I IFNs (IFN-I), respectively, in tetrapods [9–11]. A new study discovered ancestral IFN
orthologs of all three IFN types in a cartilaginous fish, and hence resolved that three types of IFNs were
ramified before the bony fish [12]. We annotated IFN gene families across 110 vertebrate genomes,
and showed that IFN genes, after originating in jawed fishes, had several significant evolutionary
surges regarding the numbers of IFN-coding genes and subtypes in some species of amphibians, bats,
and ungulates (particularly pigs and cattle of livestock) [13–15]. Here, we review the newly identified
IFN molecular evolution and expansion in amphibians [12,13,16].
The evolution of intronless (or single-exon) IFN genes and further molecular diversification
in amniotes are signature events in IFN evolution [11–16]. However, our understanding of this
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process is elusive, partly due to the unrecognized role of amphibians in IFN evolution [9–11].
Previous studies have: (1) Only discovered several intron-containing IFN progenitors in amphibians [9],
and (2) underestimated IFN-mediated antimicrobial responses in amphibians and the unique role of
amphibians in IFN evolution. Previously, the emergence of intronless IFN genes has been assumedly
ascribed to reptiles, which further suggested a linear-increasing model for IFN diversification from
fish to mammals [9,10]. Our recent research detected the unexpected emergence and expansion of
intronless IFN genes in amphibians, exemplified by 40–50 predicated IFN-coding genes, of which
24–37 are intronless in each Xenopus species [13]. This remarkable coexistence of intron-containing
and intronless IFNs in amphibians confirms that the emergence of intronless IFN genes actually
occurred in amphibians (or even earlier in fish) in contrast to previously hypothesized in reptiles [13,16].
These findings determined previously unknown and species-independent expansion of intronless IFN
genes in amphibians, which revises the established model of IFN evolution and highlights the critical
role of amphibian IFN complex in studying IFN biology (Figure 1) [11–16].
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Figure 1. Schematic of vertebrate interferon (IFN) evolution and recent discovery about amphibian
IFN complex. Evolutionary analyses were conducted in MEGA X [17]. The minimum evolution (ME)
method was used to infer the molecular phylogeny, and the evolutionary distances were computed
using the p-distance method, shown in the units of the number of amino acid differences per site.
The ME tree was searched (search level of 1) using the close-neighbor-interchange (CNI) algorithm.
The analysis used 108 amino acid sequences. All ambiguous positions were removed for each sequence
pair. There was a total of 437 positions in the final dataset. In contrast to the previously known several
fish-like intron-containing amphibian IFNs, recent studies revealed that amphibians are unique to have
both fish-like intron-containing and amniotic intronless IFNs, which molecularly and immunologically
stamp their amphibiotic position in vertebrate evolution [12,13,16]. Legends and Abbreviations: IFN-I,
type I IFNs (including amniotic intronless IFNA, IFNB, IFNE, IFNK, IFNW, respectively, for the genes of
IFN-α, -β, -ε, -κ, -ω; and diverse amphibian intron-containing, XaIFN or XtIFN, and intronless XaIFNX
or XtIFNX, listed here); IFN-III, type III IFNs (including amniotic intron-containing IFNL gene for
IFN-λ; and amphibian intron-containing XaIFNL or XtIFNL, and intronless XaIFNLX or XtIFNLX, listed
here); SCCA 1, Scyliorhinus canicula (catshark) ancestral IFN-I; SCCA L, Scyliorhinus canicula (catshark)
ancestral IFN-III; Dr, Danio rerio (zebrafish); Gg, Gallus gallus (chicken); Hs, Homo sapiens; Xa, Xenopus
laevis; Xt, Xenopus tropicalis; Group designation: 1 and 7 & 8, intron-containing ancestral IFN-I (7 & 8)
and IFN-III (1); 2, intron-containing IFN-III in amniotes; 3 and 4, amphibian intron-containing IFN-III
(3) and IFN-I(4); 3X and 4X, intronless amphibian IFN-III (3X) and IFN-I (4X); 5X and 6X, intronless
IFN-I in amniotes.
For instance, extensive analysis of current genome assemblies of Xenopus tropicalis and Xenopus
laevis at NCBI (https://www.ncbi.nlm.nih.gov/genome/?term=Xenopus) and Xenobase (http://www.
xenbase.org/) led to the identification of 37 intronless IFN-like genes (XtIFNX) (including 4 near
intronless IFN-like genes retaining only a short (<50 bp) intron) and 3 pseudogenes in X. tropicalis [13].
Similarly, 26 intronless IFN-I (XaIFNX) genes (including 8 with a short remaining intron and 4
pseudogenes) were identified in the X. laevis genome. Notably, those amphibian short-intron-containing
IFN gene-like sequences were indicated to be rudimentary intermediates of the retro(trans)position
event that further became intronless IFN genes. Our annotation of the current genome assemblies at
NCBI and Xenbase not only determined intronless IFNs in frogs for the first time, but also discovered
several more intron-containing IFNs, which were not revealed in previous studies. We therefore
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updated the current repertoire of IFN gene loci in X. tropicalis: The co-existence of 14 intron-containing
IFNs (7 IFN-I, 1 IFN-II, and 6 IFN-III) and the expansion of 37 intronless IFN-like genes (36 IFN-I and
1 IFN-III); and in X. laevis: 17 intron-containing (7 IFN-I, 1 IFN-II, and 9 IFN-III) and 24 intronless
IFN-coding genes (22 IFN-I and 2 IFN-III) (Table 1 and Figure 1) [13]. A new study in a Tibet frog
species (Nanorana parkeri) reinforced the co-existence of both intron-containing and intronless IFN genes
in amphibians [16]. However, the expansion of antiviral IFN genes in different amphibian species,
especially the intronless ones, seems species-independent. These intronless amphibian IFN genes
seem to have a paralogous rather than an orthologous relationship, as well as to the amniote intronless
IFNs [12,13,16]. All of these studies collectively determined the unique coexistence of intron-containing
and intronless IFNs in both IFN-I and IFN-III in amphibians [12–16]. These findings support that the
retroposition process, which initiated the evolution and expansion of intronless IFNs in higher amniotes,
evidently originated in amphibians or earlier, rather than in reptiles as previously believed [9–13,16].
The species-independent expansion of intronless type I IFNs in amphibians suggests a unique role
of amphibians in IFN evolution. Indeed, collected evidence also indicates an evolutionary benefit of
these intronless IFN genes in gene expression and efficient contest to infectious and developmental
pressures during adaption to terrestrial lives [11–14,16,18–20].
Table 1. Molecular composition of amphibian IFN complex compared with IFNs in amniotes (human)
and fish (catshark).
IFN Type Gene/Subtype * Fish: Catshark Amniotes: Human
Amphibian




















* Gene number/subtype number. Subtype classifications are based on both molecular phylogeny and function for
amniotic IFNs (human), but primarily molecular phylogeny in amphibian IFNs [12,13].
Amphibians are an irreplaceable link in animal evolution toward terrestrial tetrapods. They reside
in aquatic, terrestrial, and arboreal habitats, and are sensitive indicators for monitoring the
environmental and habitat changes in our bio-ecosystem. In basic science research, amphibians have
long been utilized as prominent models for studying physiological and developmental processes [21–24].
Due to the crucial role that amphibians play in both the ecosystem and experimental sciences, it
is imperative to gain a better understanding of their immunobiology. Recent investigations have
indicated that pathogenic factors (such as by chytrid fungus and Ranavirus) are causing amphibian
population decline and threaten global biodiversity [25–31]. This further emphasizes the need to study
the amphibian immunome and its interaction with epidemic pathogens [1–3,32–40]. Amphibians
have several unusual characteristics that are stimulating for immunobiological studies [32,33,35,39].
For example, amphibians have moist and permeable skin, which also serves as an organ for
respiration [33,34]. Previous studies have discovered that amphibian skin is one of the most generous
sources of antimicrobial peptides, of which some are broadly effective and potentially therapeutic
against bacteria, fungi, viruses, and even cancers [37,38,41–45]. Recent studies in the amphibian
IFN system uncovered another unique advantage—that amphibians give rise to the emergence
and expansion of intronless IFN genes [12,13,16], which archive the primitive diversity of the IFN
system prior to further evolve in higher vertebrates, including humans [1,12]. Therefore, not only
are amphibians unique for the study of the signature event of IFN evolution that leads to antiviral
superiority of intronless IFNs in amniotes, but amphibian models are also irreplaceable in order to
determine the evolutionary coordination and functional diversity among the IFN subgroups [12–16].
This is because amphibians represent the only animal clade to have both IFN gene subgroups (intronless
vs. intron-containing) in either IFN-I or IFN-III types (Table 1 and Figure 1) [12–16].
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2. The Fish-Like Intron-Containing IFN Genes in Amphibians
Two types of fish IFN genes, generally one to several IFN-γ and several IFN-φ (current
nomenclature as fish IFN-a/-b/-c/-d, etc.) genes in each species have been previously only found in
teleosts [10–12]. As fish IFN-γmanifests orthologous phylogeny with the IFN-II identified in tetrapods,
it is uncertain about IFN-φ genes, which were proposed to be ancestral molecules for either IFN-I or
IFN-III, or both, found in tetrapods. Per gene structure, all fish IFN-φ genes contain about four introns,
which resemble what have been observed in most IFN-III genes but not IFN-I genes in amniotes,
where most IFN-I genes are intronless [10–12,46–49]. Examination of the proteins coded by fish IFN-φ
genes indicated that they contain either two or four cysteines to form into intra-molecular disulfide
bonds critical for IFN tertiary conformations and potential antiviral potency [10–12]. A recent study
identified an ancestral IFN-III gene in searching transcriptome of catshark, a cartilaginous fish [12]. This
resolves that the jawed vertebrate ancestor has orthologs of all three interferon types [12]. Therefore,
the IFN-φ genes previously discovered in bony fish, including both two- and four-cysteine groups, are
determined to be in the IFN-I lineage, even though they may not be orthologous to tetrapod intronless
IFN-I genes [46–49].
Amphibians bridge vertebrate evolution from the water to terrestrial lives. From the perspective of
IFN evolution, previous studies only found several intron-containing IFN genes belonging to IFN types,
which thus assumed more ancestral conservation than rapid IFN evolution in amphibians [9,11]. In
spite of this, extensive inspection of current Xenopus genome assemblies identified 6–9 intron-containing
IFN genes in both IFN-I and IFN-III types, which indicated a moderate gene expansion to compare to
that identified in most fish species (Figure 1 and Table 1) [9,12,13]. Most amphibian intron-containing
IFN genes encode a protein with four cysteines, with some exceptions of two or three cysteines in both
IFN-I and IFN-III types [9,12,13,16]. Phylogenically, Xenopus intron-containing IFN-I genes belong to
two groups (Group 4s in Figure 1): One (consisting of only three IFN genes) falls sister to fish ancestral
and tetrapod IFN-I genes, and another group sisters amphibian intronless IFN-I genes (Figure 1).
This indicates that amphibian intron-containing IFN genes might experience less birth–death rates
than their amniotic intronless counterparts to preserve potential orthologs that derived into IFN
lineages discovered in tetrapod [12]. In addition, these primitive amphibian IFN genes also adapted to
evolve into different subgroups of intronless IFN genes, which believably have more rapid birth–death
dynamics to evolutionarily cope with pathogenic and physiological pressure during the amphibiotic
stage of vertebrate evolution [11,12].
3. The Expansion of Amniote-Like Intronless IFN Genes in Amphibians
In addition to the conservation of intron-containing IFN genes, the co-existence of intronless IFN
genes inscribes the amphibiotic role of amphibians in vertebrate evolution [12,13,16,50,51]. Prior to
identification of intronless IFN genes in amphibians, a prevalent model for IFN evolution described
that a retroposition process happened in reptiles and led to the origin and expansion of intronless
IFN-I genes in amniotes [9,10]. The discovery of intronless IFN genes in amphibians revised this
model and confirmed that the emergence of intronless IFN might happen in amphibians or even
earlier. Indeed, the earliest existence of intronless IFN genes so far was only detected independently in
different species of amphibians [12,13,16,50,51]. Genes without introns are a characteristic feature of
prokaryotes; however, a small portion of intronless genes also exist (even emerge) in animal genomes,
including all mammalian species. In eukaryotic cells, genes use introns to enhance transcription fidelity,
i.e., intron–exon splicing inhibits topoisomerase-I cutting activity to reduce mutagenesis generated
during gene transcription [52]. On the other hand, intronless genes express more rapidly upon stimuli,
and duplicate or mutate more efficiently for new gene evolution [50,52]. In this line, intronless IFN
gene evolution may represent a prokaryote-wise arm race adapted by animal immunity at a molecular
level [50].
Amniotic IFN-I genes are almost all intronless, which have been classified into multiple subtypes,
including IFN-α, IFN-β, IFN-δ, IFN-ε, IFN-κ, IFN-τ, IFN-ω, and IFN-ζ, commonly (IFN-α, IFN-β, IFN-ε,
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and IFN-κ) or species-specifically (IFN-δ, IFN-τ, IFN-ω, and IFN-ζ) expressed in mammalians [11–16].
Birds and reptiles also possess several to a dozen intronless IFN-I genes in each species, which have
also been named such as IFN-α and IFN-β, however, are not necessarily orthologs (but paralogs)
to their mammal counterparts [11,12]. Amphibians contain intronless IFN genes of both IFN-I and
IFN-III types. This is unique among all studied vertebrate species because amniotic IFN-I genes are
generally intronless, and intron-containing IFN genes are common for all fish IFN genes and amniotic
IFN-III genes [11–16]. In the three studied amphibian species (i.e., Xenopus laevis, Xenopus tropicalis,
and Nanorana parkeri), each species may harbor several to near 40 intronless IFN genes, and the majority
of them belonging to IFN-I types [12–14,16,50,51]. Intronless Xenopus IFN-I genes were grouped
into four groups based on their intermolecular sequence similarity, and further defined into three
clades based on their phylogenic relationship to other tetrapod species [12,13]. For example, about 10
intronless Xenopus IFN-I genes were located within the mammal and reptile IFN-I clade, next to a clade
containing only reptile sequences [12,13]. This suggests that amphibians contain orthologs of amniote
intronless IFN-I genes, and thus provide the earliest intronless ancestors (identified so far) of tetrapod
IFN-I genes [12,13]. The other intronless amphibian IFN-I genes were nested or fell sister to fish
intron-containing IFN genes, indicating their close phylogeny to these primitive ancestors as well [12].
Intriguingly, several Xenopus IFN-I genes were found to contain a single short intron and were assumed
to be intermediate molecules recoding the intron loss process [13]. One of these small-intron containing
Xenopus IFN-I genes located sister to the group of cartilaginous fish IFN-I genes that were next to the
intronless amniote IFN-Is in a recent phylogenic analysis [12]. Thus, the intronless amphibian IFN-I
genes consist of a complex of tetrapod IFN intermediates between fish intron-containing ancestors and
amniotic IFN-I genes; however, a one-to-one orthologous relationship is yet to be determined between
amphibian and amniotic intronless IFN genes [12,13].
In addition, amphibians are among the few tetrapod species having intronless IFN-III
genes [12,13,51]. Studies indicated that intronless IFN-III genes have evolved at least twice during
amphibian evolution [12]. We also detected the co-existence of intronless IFN-III genes in many
amniotic species, and hence, at least three times intron loss has happened throughout vertebrate
evolution [14]. However, intronless IFN-III genes experienced much less expansion potency than
intronless IFN-I genes in tetrapods. It is unclear what kind of molecular or phylogenic mechanisms
underlie this difference between IFN-I and IFN-III genes (Table 1 and Figure 2) [11–16].
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Figure 2. An updated model for antiviral IFN (IFN-I and IFN-III) gene evolution in vertebrates.
The ancestral genes of three type of IFNs (IFN-I, -II, and -III) have been identified in cartilaginous fish.
All fish IFN genes are intron-containing ones generally with four introns (or five exons) [12]. In contrast,
amniotic IFN-I genes are generally intronless. Co-existence of multiple intronless and intron-containing
IFN genes were only detected independently in different species of amphibians [12–16,50,51].
The current evidences support that at least two retroposition events might have happened in
amphibians, at about 180.70 MYA (million years ago) in Xenopus and 87.57 MYA in N. parkeri,
for example [12–16,50,51]. These two independent retroposition events might have occurred much
later than the divergence between amphibians and amniotes (i.e., ~350 MYA, orange dot). Another
retroposition event leading to intronless IFN orthologs in amniotes could also happen in accompaniment
to loss of intron-containing IFN genes in reptiles; however, it could be unlikely if an orthologous
relationship exists between different intronless amphibian IFNs with amniotic ones [12]. The emergence
and expansion of intronless amphibian IFNs likely reflect the increasing evolution pressure (especially
the air-borne pathogens and physiological requirement for terrestrial adaptation, shown with broad
curve arrows) during the transition period, when vertebrates migrated from aquatic to terrestrial
environments. Retroposition defines a reverse-transcription process of cellular mRNA and reintegration
into the genome to enhance gene copying and evolution in molecular evolution. Compared to intronless
IFN-I genes, one paradox in IFN evolution is why IFN-II and –III genes conserve the ancestral gene
structures, and do not show gene expansion even after few intronless IFN-III genes originated in
amphibians and other amniotes. Solid or dashed black arrows: Indicating certain or uncertain
orthologous relationships discovered, respectively.
4. Phylogenic View and Evolutionary Postulation about Amphibian IFN Evolution
In Figure 2, we summarize the current understanding of IFN evolution to highlight several
key points and the newly discovered IFN complex in amphibians [12–16,50,51]. First, the ancestral
molecules of three types of IFNs were identified in cartilaginous fish, indicating the earlier ramification
of IFN primitive genes in fish [12]. This elegant discovery concludes a dispute about whether the
fish IFN-φ genes are ancestral to tetrapod IFN-Is or IFN-IIIs to indicate that they all belong to IFN-Is,
except a recently found SCCA-L from catshark, which is a fish IFN-III gene [12]. A question remains: Is
that why no other IFN-III genes have been detected in bony fish so far? Extinct after the emergence or
originated in a species- or taxon-independent manner? Second, intronless IFN genes in both IFN-I and
IFN-III genes co-exist with intron-containing IFN genes, and this extensive co-existence has only been
detected in different species of amphibians [12,13,16,50,51]. This indicates that the retroposition events
that led to the emergence of intronless IFN genes happened several times in a species-independent way
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in amphibians [12,13,16,51]. Therefore, amphibians also comprise a unique animal taxon, containing
both intronless and intron-containing IFN genes in both IFN-I and IFN-III types. Notably, intronless
IFN-I genes but not IFN-III genes have experienced a rapid gene expansion, probably through a
recently proposed birth–death process in Xenopus [12,13,16,51]. We propose that the emergence and
expansion of intronless amphibian IFNs likely reflect the increase evolution pressure (especially the
air-borne pathogens and physiological requirement for terrestrial adaptation) during the transition
period when vertebrates migrated from aquatic to terrestrial environments. So why did intronless
gene expansion happened in Xenopus but not obviously in Nanorana [13,16,51]? Maybe habitats close
to human or domestic areas provides an epidemiological explanation [14,15]. Compared to intronless
IFN-I genes, one paradox in IFN evolution is why IFN-II and –III genes conserve the ancestral gene
structures, and do not show gene expansion even after few intronless IFN-III genes originated in
amphibians and other ammonites. Recent studies discovered the epithelia-specified expression pattern
and less-inflammatory activity of IFN-IIIs in mammalian studies [53–57]. It deserves investigation of
whether this anatomic or physiological ramification limits the expansion potency of intronless IFN-III
genes in tetrapods.
5. Amphibian IFN Complex: Expression and Function in Antiviral and Other Immune Responses
Described first for “interfering” with influenza virus in cultured chicken cells [58], IFNs are key
antiviral cytokines and have multiple functions in immune regulation [4–7]. Nevertheless, most IFN
functional studies have been conducted using mammal models, and amphibian IFNs remain largely
uncharacterized. Previously, only several intron-containing IFN-I and IFN-III genes were identified in
amphibians; and Xenopus IFN-III genes were ubiquitously detected in multiple tissues from healthy
adult frogs [9,59,60]. Xenopus tissues or cells treated with poly (I:C) or infected with Ranavirus (FV3)
robustly stimulated the expression of both types of IFN genes and their corresponding receptors.
In Xenopus kidney cells and tadpole models, administration of recombinant IFN peptides of either
Xenopus IFN1 or an IFNλ induced the expression of ISGs, including IFIT5, PKR, and MX1 [9,59,60].
The recombinant Xenopus IFN1 peptides protected the kidney-derived A6 cell line and tadpoles against
FV3 infection, showing the decrease of the infectious viral burdens in both cases [59,60]. The study
also observed that adult frogs were naturally more resistant to FV3 and were able to clear the infection
within a few weeks, whereas tadpoles typically could not get over the viral infections. Correspondingly,
adult X. laevis frogs demonstrated significantly higher FV3-elicited IFN gene expression than tadpoles,
indicating that IFN response at least partly determined the antiviral consequence [59,60]. Even though
IFN treatment markedly impaired viral replication and viral burdens in tadpoles, it only transiently
increased tadpole survival time and did not change the final mortality rate of infected tadpoles due to
considerable organ damage, regardless of IFN treatment in FV3-infected tadpoles [59,60]. Therefore,
these studies revealed that amphibian intron-containing IFNs may consist of a basic immune barrier,
even in healthy frogs; however, the undeveloped or irresponsive IFN status may contribute to the
vulnerable consequence in tadpoles, which ascribe to a major portion of animal death in amphibian
decline [59–62].
Genome-wide identification of intron-containing and intronless IFN genes in Xenopus and Nanorana
species allows characterizing amphibian IFNs more extensively, in particular for the intronless
subgroups [13,16]. The constitutive expression of multiple intronless IFN genes in X. laevis was
demonstrated in most tested tissues, with a particular high expression in lung and heart [13]. The two
intronless IFN-III genes were expressed in skin, stomach, and kidney. Similarly, the intron-containing
IFN4 had the highest expression in kidney and heart. In contrast, IFN genes (such as the intronless
IFNX3 and IFNLX group) that showed high inductive response (see context next) generally had a
low expression level in normal tissues [13,50]. In addition to our gene-targeting expression analysis,
most intronless IFN genes in X. tropicalis genome were also heavily mapped by RNA-Seq reads
deposited at the public domains of NCBI, indicating functional expression of these less-studied
amphibian IFNX genes (Table 2) [13].
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Table 2. Functional knowns and unknowns about amphibian IFN complex referring to well-studied amniotic IFNs.
IFN Type Function Properties [1–7] Amniote: Human and Mouse [1–7,53–59] Amphibian [13,16,59–62]
Principal producer cells
Basically all nucleated cells, but major producers:
Leukocytes (IFN-α), fibroblasts (IFN-β),
macrophages/pDCs (IFN-α), epithelial cells (IFN-ε/-κ)
Major tested cells: Bone marrow-derived macrophages,
skin cells, and kidney cells
Inducing agents Viruses, dsRNA, CpG, IFNs Viruses, dsRNA, ssRNA, CpG, IFNs(?)
Classical activity:
IFN-I





• Yes, direct evidence from IFN-α/-β/-ω subtypes
• Yes, many viruses in vitro/vivo
• Differentially of subtypes in various cell types
• Yes, in cancer/tumor cells
• Regulation of inflammation, B-cell and T-cell
generation and activation
• Probably, IFNAR1/2 and most
• ISGs are there, limited evidence









• IFN-β: Microbiota; IFN-α: Embryonic HSC; IFN-ε:
Reproductive tract; IFN-κ: Keratinocytes
• IFN-ω/τ (in pigs and cattle)





Principal producer cells Activated T cells, NK cells, macrophages No direct evidence, maybe similar to amnioticcounterpart
Inducing agents Mitogens, antigens, and IL-2 LPS, dsRNA, mitogens/antigens/IL-2(?)
Major activity Immune regulation on leukocytes; antimicrobial, antitumor Incomplete evidence, maybe similar to amnioticcounterpart
Principal producer cells Epithelial cells, BMCs, blood cells Skin cells, kidney cells, and macrophages
Inducing agents Similar to agents for IFN-I Similar to agents for IFN-I
Major activity:
IFN-III




• Direct evidence from IFN-λ1/λ3
• Especially for gut and respiratory tract
• Yes, prone to functional protection on mucosa
• Yes, act through activation of neutrophils
• No direct evidence, maybe similar to
amniotic counterpart
• May not limit to epithelia (?)
• Unknown
• Potential, incomplete evidence
Acronyms: AMPK, AMP-activated protein kinase; BMC, bone marrow cells; CpG, synthetic DNA motif of TLR9 ligand; dsRNA, synthetic double-strand RNA; FV3, frog virus 3; HSC,
hematopoietic stem cell; IFN, interferon; IFNAR, IFN-I receptor; IFNLR, IFN-III receptor; IL, interleukin; ISG, IFN-stimulating genes; LPS, Lipopolysaccharide; mTOR, mammalian target of
Rapamycin; NK cell, nature killer cell; ssRNA, single-strand RNA.
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Similarly, in the N. parkeri, an intron-containing IFN-I gene was highly expressed in kidney and
intestine, as well as two intronless IFN-I genes in the lung, intestine, and skin, constitutively [16].
More than a 100-fold stimulation of the two intronless IFN genes was observed post-treatment of
tissues (spleen, kidney, and liver) using poly(I:C) for 3–24 h [16]. More extensive inductive expression
of amphibian IFN genes was compared in a kidney cell line from X. laevis (A6) after treatment of the
cells with representative microbial mimics [13]. For example, intron-containing IFNs (represented by
IFN4) were constitutively expressed at 5 h, but clearly showed inductive expression after cells were
treated for 24 h. The viral dsRNA mimic, poly (I:C), most effectively stimulated several subgroups
of IFNs, including both intron-containing and intronless IFNs in both IFN types at either 5 h or 24 h
post-treatment. On the other hand, TLR2 and TLR4 ligands (Pam2/3CSK4/LTA and LPS, respectively)
induced these same IFN expressions especially at 24 h post-treatment. Treatments with the ligands for
TLR2/6 (Pam2CSK4) and TLR4 (LPS), but not ligands for TLR2/1 (Pam3CSK4) or TLR2 only (LTA),
stimulated significant IFN expression. This indicates the differential regulation among amphibian IFN
subgroups regarding defense responses against different pathogens [13].
The results from Xenopus tadpoles and adult frogs were more conclusive toward biological
significance [61,62]. Using primary skin and kidney cells, Wendel et al. showed that most IFN
genes were differentially expressed in the two cell types treated with various pathogenic mimics [62].
The findings include: (1) With few exceptions, most intron-containing IFN-I genes were more inductive
in tadpole skin cells; (2) most intronless IFN-I and all IFN-III genes were more inductive in adult
skin cells; and (3) the majority of IFN genes showed stronger induction in tadpole kidney cells;
however, CpG DNA stimulated more robust IFN response in the adult kidney cells (Table 2). Post-FV3
infection, the expression of nine representative IFN genes (including six IFN-I and three IFN-III of
both intron-containing and intronless groups) were increased 3–25-fold in the FV3-infected skin cells
from both tadpoles and adult frogs; however, a robust stimulation (10–400-fold increase) of these
IFN genes was detected in FV3-infected kidney cells from adult frogs, whereas negligible increases
were detected in FV3-infected tadpole kidney cells [61,62]. Not only susceptible to amphibian FV3
infections, our data showed that frog kidney cells were also permissive to an influenza virus (H1N1
TX98) [13]. The flu virus infection induced a moderate increase of IFN4 and IFN-III gene expression
at a low virus titer (multiplicity of infection or MOI at 1). A higher than 100-fold increase of these
virus-responsive IFNs was detected in cells infected with the virus at a high MOI for 48 h. In addition,
a strong expression of most intronless type I IFNs was shown in cells infected with the virus at 10 MOI,
indicating a robust IFN reaction upon a massive viral infection [13]. In summary, the expression of
these amphibian IFNs, particularly the intronless subgroup, was experimentally validated and shows
differential expression in the ex vivo stimulated cells and animal tissues. Both the constitutive and
inductive expressed patterns under various stimuli indicate the functional diversity of amphibian IFN
complex as components of the innate immune system [13,16,59–62].
The antiviral activity of amphibian IFN peptides has been tested in both cells and
animals [13,16,59–62]. Grayfer et al. produced a recombinant Xenopus IFN1 peptide using an
insect cell-expression system [59,60]. The IFN1 peptide actively protected frog kidney cells against
FV3 infection, and strongly induced MX1 (a robust antiviral ISG) expression in multiple tissues after
administration into tadpoles for 24 h. In animal tests, the recombinant IFN1 peptide reduced viral
burdens; however, did not improve the final mortality rate caused by FV3 infection in tadpoles [59,60].
Gan et al. tested the antiviral activity of N. parkeri intronless IFNi1 and IFNi2 by direct transfection
of the IFN genes in a mammalian-expression vector into Xenopus kidney cells (A6 cells) [16].
They demonstrated that the transfection of IFNi1 and IFNi2 constructs induced the expression
of serval typical ISGs and protected the cells against FV3 infection in the Xenopus kidney cells only if the
IFNAR receptor genes of N. parkeri were co-transfected [16]. This indicates that there is a cross-species
barrier of IFN antiviral activity due to species-specific IFN–IFNAR engagement in amphibians, further
supporting the species-specific co-evolution of amphibian intronless IFN genes and corresponding IFN
receptors [11–16]. We also used a mammalian-expression system to produce 15 Xenopus IFN peptides
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and determined their different antiviral activity against an influenza virus [13–15]. Antiviral assays
by direct transfection of A6 cells using IFN-expressing constructs indicated that typical candidates of
each amphibian IFN subgroup induced antiviral protection and reduced virus titers in A6 cells. In
conclusion, the tested intron-containing IFN group (including IFN4, IFN6, and IFN7), which had higher
activity against the viral cytopathic effect, are generally less active in suppression of viral replication. In
contrast, the intronless IFNs demonstrated higher virus suppression, but were less effective to protect
cell death from the viral infection [13,14]. Comparatively speaking, most Xenopus type III IFNs were
less active in antiviral activity, except an IFNL4 that showed stronger virus-suppressive activity than
most type I IFNs tested. Another significant IFN example was IFNX4, which demonstrated remarkable
virus-suppressive and cell protective activity similar to most intron-containing IFNs tested. Clearly,
all of these antiviral analyses validate that the Xenopus IFN complex comprises a profound antiviral
diversity considering their antiviral activity against the influenza and FV3 infections [13,16,59–62].
The immune role of amphibian IFNs against other intracellular pathogens has also been recently
tested [13]. Listeria monocytogenes represents a prevalent intracellular bacterial pathogen such as in
food safety and public health. We detected that in the bacteria-infected A6 cells, most amphibian
IFNs were highly stimulated when the cells were intracellularly infected with the bacteria. In all tests
where cells were with different bacterial dosages, the intronless IFNX3 group was highly stimulated.
This indicated that this intracellular IFN subtype (lack of signal peptides for secretion) might have
evolved to regulate antibacterial activity inside cells. In cell cultures with a gel-overlay to restrict
the bacterial intracellular growth, most IFN-expressing constructs showed antibacterial to some
extent. However, most IFNs lost their antibacterial activity without a gel-overlay to limit the bacterial
extracellular spreading. We also noted that IFNX2, the intracellular IFN isoform, developed significant
antibacterial activity in both test conditions (with or without gel-overlay). Indeed, both intronless
IFNX2 and IFNX3 are among the IFNX3 group, which showed the most antibacterial activity and
were among the most inductive IFN genes in cells infected with L. monocytogenes, or treated with
the ligands for either TLR2 (Pam2CSK4) or TLR4 (LPS) [13]. Considering that IFNX2 and IFNX3 are
intracellular IFN peptides that lack a signal peptide for secretion, they potentially induce protective
activity against intracellular bacteria via intracellular signaling pathways that are different from
canonic IFN signaling through binding the membrane-bound IFNAR receptors [13,14,63]. Interferons
and some ISGs (such as numerous IFN induced very large GTPase gene analogs) were found to be
upregulated throughout Chytridiomycosis, a fungal skin infection that caused amphibian declines in
several amphibian species [34,64]. Currently, there is lack of studies about the antifungal effects of
amphibian IFNs. Several recent studies revealed a coordination between mouse type I IFNs and type
III IFNs to regulate antifungal immune responses. Showing that during a fungal infection caused by
Aspergillus fumigatus, type I IFNs produced by monocytes signaled the epithelial production of type III
IFNs, which in turn played a critical role in regulating the antifungal neutrophil responses [65–67].
Given the diverse IFN-III genes evolved in amphibians, we expect to determine some amphibian
IFN-IIIs that are important in antifungal immune response. In summary, recent studies conclude that
the amphibian IFN family has a differential expression pattern and exerts a regulatory role in antiviral,
antibacterial, and potential antifungal immune responses [13,16,59–62]. In addition, studies in amniotic
IFNs also determined the multifunctional properties of antiviral IFNs in the regulation of immune
cell development and metabolism, as well as animal pregnancy [68–71]. Whether amphibian IFN
complex evolves to have similar functional diversification warrants further investigations in vertebrate
physiology and development.
6. Conclusive Remarks: Amphibian IFN Complex—A Molecular Signature of Vertebrate
Immune Evolution
Several recent studies have revealed a previously unknown complexity of the amphibian IFN
system [11–16]. Being unique to animals from any other classes of vertebrates, amphibians not only
conserve and multiply the fish-like intron-containing IFN genes, but also rapidly evolve amniote-like
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intronless IFN genes in three tested species [13,16,51]. Amphibians are thus critical intermediate species
in IFN (and potentially other immune gene families too) evolution, in addition to their key position in
studies of vertebrate development [24,35,40]. We postulate that the amphibian IFN system provides
an irreplaceable model to study vertebrate immune evolution in molecular and functional diversity
to cope with unprecedented immuno-physiological requirement during terrestrial adaption [11–16].
Studies so far have ascribed a defense role of these IFNs in immune regulation against intracellular
pathogens particularly viruses and bacteria [13,16,59–62]; however, many knowledge gaps remain
to be completed. Based on recent reports about IFN’s multifunctional properties in regulation of
animal physiological and defense responses, we interpret that amphibian IFNs may evolve novel
function pertinent to their superior molecular diversity [4–7,11–16]. Such new function revealed by
the emerging studies of antifungal and developmental regulation of amphibian IFNs will certainly
promote our understanding of immune evolution in vertebrates to address current pathogenic threats
causing amphibian decline [25–29]. Xenopus is proposed as an alternative model for cancer studies
due to its evolutionary tumor immunity [35]. Antitumor activity constitutes another key function of
the antiviral IFNs [6]. We therefore expect that the amphibian IFN complex may have evolved IFN
molecules bearing superior antitumor activity, and the Xenopus tumor immunity model can contribute
to the development of IFN-based cancer immunotherapies [6,35].
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